Concepedia

Eva Vets

EV

Statistics

Publications

9

Citations

542

H-Index

9

Active since

2007

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Universität Hamburg

University Medical Center Hamburg-Eppendorf

United States Military Academy

Eva Vets is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, immunology, and clinical pharmacology.

Top concepts

Publications per year

2007–2016

9

Publications

9

Suppression of Niacin-induced Vasodilation with an Antagonist to Prostaglandin D2 Receptor Subtype 1

Eseng Lai, Inge De Lepeleire, TM Crumley et al. · Clinical Pharmacology & Therapeutics · 2007 · 149 citations

Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults

Isabel Leroux‐Roels, Eva Vets, Ralf Freese et al. · Vaccine · 2008 · 121 citations

, , +10

A Phase 1 Study to Evaluate the Safety and Immunogenicity of a Recombinant HIV Type 1 Subtype C Adeno-Associated Virus Vaccine

Sanjay Mehendale, Jan van Lunzen, Nathan Clumeck et al. · AIDS Research and Human Retroviruses · 2008 · 55 citations

On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly

Annemiek Vermeeren, Eva Vets, Eric Vuurman et al. · Psychopharmacology · 2016 · 50 citations · Full text

Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of JNJ-38431055, a Novel GPR119 Receptor Agonist and Potential Antidiabetes Agent, in Healthy Male Subjects

Leonid Katz, Jay J. Gambale, Paul Rothenberg et al. · Clinical Pharmacology & Therapeutics · 2011 · 48 citations

1–5 of 9